Ovid Therapeutics Inc. · NASDAQ:OVID
BlackRock, Inc. reported a 5.80% stake in Ovid Therapeutics Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 5.80% stake in Ovid Therapeutics Inc., 10,822,672 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 10,822,672
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.80% | 10,822,672 |
Source
Related
- Ovid Therapeutics Inc.
- BlackRock, Inc.
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026